Evidence map›Paper›PMID 37416336›Full record

ArticleJournal of radiosurgery and SBRT2022

Stereotactic body radiation therapy for an unresectable FGF23-secreting tumor of the cervical spine: A case report and literature review.

Kathryn Hockemeyer, Juhi M Purswani, Joseph K Kim, Babak Givi, Elcin Zan, Donato Pacione, Maksim Shapiro, Ilya Laufer, Jill B Feffer, Joshua S Silverman

Open access · greenAbstract read
In one paragraph

Article in Journal of radiosurgery and SBRT, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 76% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Kathryn HockemeyerDepartment of Radiation Oncology, NYU Langone Health and Grossman School of Medicine, New York, NY, USA.
Juhi M PurswaniDepartment of Radiation Oncology, NYU Langone Health and Grossman School of Medicine, New York, NY, USA.
Joseph K KimDepartment of Radiation Oncology, NYU Langone Health and Grossman School of Medicine, New York, NY, USA.
Babak GiviDepartment of Head and Neck Surgery, NYU Langone Health and Grossman School of Medicine, New York, NY, USA.
Elcin ZanDepartment of Radiology, NYU Langone Health and Grossman School of Medicine, New York, NY, USA.
Donato PacioneDepartment of Neurosurgery, NYU Langone Health and Grossman School of Medicine, New York, NY, USA.
Maksim ShapiroDivision of Interventional Neuroradiology, Department of Radiology, NYU Langone Health and Grossman School of Medicine, New York, NY, USA.
Ilya LauferDepartment of Neurosurgery, NYU Langone Health and Grossman School of Medicine, New York, NY, USA.
Jill B FefferDivision of Endocrinology, Diabetes, and Metabolism, Department of Medicine, NYU Langone Health and Grossman School of Medicine, New York, NY, USA.
Joshua S SilvermanDepartment of Radiation Oncology, NYU Langone Health and Grossman School of Medicine, New York, NY, USA.
NYU Langone Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present the case of a 65-year-old male with tumor-induced osteomalacia (TIO) caused by an FGF23-secreting phosphaturic tumor of C2 treated definitively with stereotactic body radiation therapy (SBRT) and kyphoplasty. The patient exhibited notable reduction in FGF23 6 weeks following radiotherapy. He also received a dose of the FGF23 monoclonal antibody, burosumab. We discuss the case with emphasis on radiation in the management of TIO. This case demonstrates SBRT as a well-tolerated local treatment option for the management of unresectable FGF23-producing tumors.

Indexed as

FGF-23kyphoplastySBRTtumor-induced osteomalacia

Identifiers

PMID37416336
PMCPMC10322171
OpenAlexW4383480629

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.